One year in review: novelties in the treatment of rheumatoid arthritis

被引：0
作者：
Guidelli, G. M. [1 ]
Barskova, T. [2 ]
Brizi, M. G. [1 ]
Lepri, G. [2 ]
Parma, A. [3 ]
Talarico, R. [3 ]
Cantarini, L. [1 ]
Frediani, B. [1 ]
机构：
[1] Univ Siena, Dept Rheumatol, Policlin Le Scotte, I-53100 Siena, Italy
[2] Univ Florence, Rheumatol Unit, Dept Expt & Clin Med, Azienda Osped Univ Careggi, Florence, Italy
[3] Univ Pisa, Rheumatol Unit, Dept Clin & Expt Med, Pisa, Italy
来源：
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY | 2015年 / 33卷 / 01期
关键词：
rheumatoid arthritis; treatment; novelties; QUALITY-OF-LIFE; INADEQUATE RESPONSE; DOUBLE-BLIND; PHASE-II; MONOCLONAL-ANTIBODY; JOINT DESTRUCTION; TOFACITINIB CP-690,550; TACROLIMUS TREATMENT; METHOTREXATE; PLACEBO;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Rheumatoid arthritis (RA) is a chronic disease characterised by inflammation of the synovial tissue in joints, which can lead to joint destruction. The primary aim of the treatment is to control pain and inflammation, reduce joint damage and disability, and maintain or improve physical function and quality of life. In this article, we provide a critical analysis of the recent literature on the novelties in the treatment of RA, with a particular focus on the most relevant studies published over the last two years.
引用
收藏
页码：102 / 108
页数：7
相关论文
共 41 条
  • [1] ALVARO-GRACIA JM, 2013, ANN SCI M ACR
  • [2] Efficacy, safety and tolerability of tofacitinib in patients with an inadequate response to disease modifying anti-rheumatic drugs: a meta-analysis of randomized double-blind controlled studies
    Berhan, Asres
    [J]. BMC MUSCULOSKELETAL DISORDERS, 2013, 14
  • [3] Tofacitinib (CP-690,550) in combination with methotrexate in patients with active rheumatoid arthritis with an inadequate response to tumour necrosis factor inhibitors: a randomised phase 3 trial
    Burmester, Gerd R.
    Blanco, Ricardo
    Charles-Schoeman, Christina
    Wollenhaupt, Juergen
    Zerbini, Cristiano
    Benda, Birgitta
    Gruben, David
    Wallenstein, Gene
    Krishnaswami, Sriram
    Zwillich, Samuel H.
    Koncz, Tamas
    Soma, Koshika
    Bradley, John
    Mebus, Charles
    [J]. LANCET, 2013, 381 (9865) : 451 - 460
  • [4] Chiu YM, 2014, CLIN EXP RHEUMATOL, V32, P898
  • [5] Randomised comparison of initial triple DMARD therapy with methotrexate monotherapy in combination with low-dose glucocorticoid bridging therapy; 1-year data of the tREACH trial
    de Jong, P. H.
    Hazes, J. M.
    Han, H. K.
    Huisman, M.
    van Zeben, D.
    van der Lubbe, P. A.
    Gerards, A. H.
    van Schaeybroeck, B.
    de Sonnaville, P. B.
    van Krugten, M. V.
    Luime, J. J.
    Weel, A. E.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 (07) : 1331 - 1339
  • [6] A non-inferiority trial of an attenuated combination strategy ('COBRA-light') compared to the original COBRA strategy: clinical results after 26 weeks
    den Uyl, Debby
    ter Wee, Marieke
    Boers, Maarten
    Kerstens, Pit
    Voskuyl, Alexandre
    Nurmohamed, Mike
    Raterman, Hennie
    van Schaardenburg, Dirkjan
    van Dillen, Nancy
    Dijkmans, Ben
    Lems, Willem
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 (06) : 1071 - 1078
  • [7] Small molecules targeting JAKs-a new approach in the treatment of rheumatoid arthritis
    Feist, Eugen
    Burmester, Gerd R.
    [J]. RHEUMATOLOGY, 2013, 52 (08) : 1352 - 1357
  • [8] FLEISCHMANN R, 2012, ARTHRITIS RHEUM, V64, P61729
  • [9] Tabalumab in Rheumatoid Arthritis Patients With an Inadequate Response to Methotrexate and Naive to Biologic Therapy: A Phase II, Randomized, Placebo-Controlled Trial
    Genovese, M. C.
    Bojin, S.
    Biagini, I. M.
    Mociran, E.
    Cristei, D.
    Mirea, G.
    Georgescu, L.
    Sloan-Lancaster, J.
    [J]. ARTHRITIS AND RHEUMATISM, 2013, 65 (04): : 880 - 889
  • [10] A Phase III, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Study of 2 Dosing Regimens of Fostamatinib in Patients with Rheumatoid Arthritis with an Inadequate Response to a Tumor Necrosis Factor-α Antagonist
    Genovese, Mark C.
    van der Heijde, Desiree M.
    Keystone, Edward C.
    Spindler, Alberto J.
    Benhamou, Claude
    Kavanaugh, Arthur
    Fudman, Edward
    Lampl, Kathy
    O'Brien, Chris
    Duffield, Emma L.
    Poiley, Jeffrey
    Weinblatt, Michael E.
    [J]. JOURNAL OF RHEUMATOLOGY, 2014, 41 (11) : 2120 - 2128
12345